Drug interactions
Adalimumab + Ciltacabtagene autoleucel
Severity: Major
Adalimumab and Ciltacabtagene autoleucel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
CAR-T recipients are prone to prolonged cytopenias and infections, and adalimumab adds immunosuppression.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Adalimumab and Ciltacabtagene autoleucel interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Free 14-day trial. No card needed.
Other interactions of Adalimumab
Other interactions of Ciltacabtagene autoleucel
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
